Female Stress Urinary Incontinence Treatment Devices Market Research and Growth to 2029

The global female stress urinary incontinence treatment devices market is now valued at US$ 702.4 million and is predicted to grow at a high CAGR of 6.2% (2022 to 2029) to reach US$ 1.07 billion by the end of 2029.

In 2021, female stress urinary incontinence treatment device sales were worth 20.5% of the global urine incontinence treatment device market. Female stress urinary incontinence treatment device shipments are likely to rise in the future as knowledge of the problem grows through government initiatives around the world.

Several regulatory and device factors, as well as industry and macroeconomic criteria, will have an impact on the market. Key market advancements include the introduction of intravaginal devices and radiofrequency treatment for the treatment of female stress urine incontinence.

Because of the disease's increasing global incidence, there has been a surge in the acceptance of female stress urinary incontinence treatment devices in recent years.

The amount of female stress urine incontinence operations conducted is increasing and is expected to be a primary driver of female stress urinary incontinence treatment device demand until 2029.

Competitive Landscape

Female stress urinary incontinence treatment device makers are investing in research and development in order to increase sales, increase revenue potential, and extend their global market presence.

Key Players

  • Boston Scientific Corporation
  • Johnson & Johnson Services Inc.
  • BD
  • Coloplast A/S
  • CooperSurgical Inc.
  • MEDGYN PRODUCTS Inc.
  • Cousin Biotech
  • Caldera Medical
  • Betatech Medical
  • FEG Textiltechnik GmbH

Read More@ https://www.futuremarketinsights.com/reports/female-stress-urinary-incontinence-treatment-device-market

Key Segments Of Female Stress Urinary Incontinence Treatment Devices Industry Survey

Female Stress Urinary Incontinence Treatment Devices Market by Product Type:

  • Sling Systems
    • Mid-Urethral Slings
    • Sub-Urethral Slings
  • Pessaries
  • Artificial Urinary Sphincters (AUS)
  • Injectable Urethral Bulking Agents

Female Stress Urinary Incontinence Treatment Devices Market by End Use:

  • Female Stress Urinary Incontinence Treatment Devices for Hospitals
  • Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
  • Female Stress Urinary Incontinence Treatment Devices for Homecare Settings

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more